Eventually, TDFA exerts its protective roles by modulating the nuclear localization of the transcription factor NF-κB P65 in epithelial cells, indicating that PAD4 inhibition may serve as a promising therapeutic approach for LPS-induced ALI [89]. The gene discussed is NFKB1; the disease is acute respiratory distress syndrome.